Gonorrhoea, a common STI, is becoming harder to treat due to antibiotic resistance. Zoliflodacin, a new antibiotic, shows promise in treating this infection, with over 90% cure rate in a recent trial. The urgency for new treatments is highlighted by rising cases and resistance issues. Teljes cikk (Euronews.com)